Novavax (NVAX) CEO Stanley Erck is hoping the U.S. Food and Drug Administration (FDA) will consider using the companys U.K. data to speed up rollout of its COVID-19 vaccine, rather than waiting until… [read more]
Sage Garden Network
Information network with friendships.
